Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
417 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05924672 | Efficacy of Ra-223 in PSMA PET Optimally Selected Patients | active not recruiting | Phase 2 | 2 | University of California, San FranciscoOTHER | 1 | Jan 14, 2026 | clinicaltrials |
| NCT05671861 | Evaluating a Low-Cost Therapeutic Device in Managing Head and Neck Cancer Patients With Radiation-Related Trismus | active not recruiting | N/A | 35 | University of California, San FranciscoOTHER | 1 | Jan 13, 2026 | clinicaltrials |
| NCT06648278 | Patient Care Outreach, Navigation, Technology and Support 2.0(COUNTS2) | recruiting | N/A | 260 | University of California, San FranciscoOTHER | 1 | Jan 13, 2026 | clinicaltrials |
| NCT04763980 | Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer | recruiting | N/A | 72 | University of California, San FranciscoOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT05746169 | Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health | terminated | — | 1,576 | University of California, San FranciscoOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT06774027 | Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer(ENCORE) | recruiting | — | 100 | University of California, San FranciscoOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT02965521 | Survivor Choices for Eating and Drinking - Colorectal Cancer(SUCCEED) | completed | N/A | 50 | University of California, San FranciscoOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT05152927 | Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy | completed | N/A | 79 | University of California, San FranciscoOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT06606028 | Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma | recruiting | — | 250 | University of California, San FranciscoOTHER | 1 | Dec 12, 2025 | clinicaltrials |
| NCT04370509 | Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery | terminated | Phase 2 | 6 | University of California, San FranciscoOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT03819140 | Continuous Versus Cyclical OCP Use in PCOS(CCOUP) | completed | Phase 4 | 51 | University of California, San FranciscoOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT02735252 | PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer | active not recruiting | N/A | 156 | University of California, San FranciscoOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT06600906 | Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer | recruiting | — | 70 | University of California, San FranciscoOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT07148245 | Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma | recruiting | — | 300 | University of California, San FranciscoOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT07121972 | Mirai-MRI: Validation of AI Models for Breast Cancer Risk | recruiting | N/A | 400 | University of California, San FranciscoOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT04110756 | ChangeGradients: Promoting Adolescent Health Behavior Change | recruiting | N/A | 200 | University of California, San FranciscoOTHER | 1 | Oct 31, 2025 | clinicaltrials |
| NCT05087849 | Intralesional HPV Vaccine for Condylomata | completed | Phase 1 / Phase 2 | 2 | University of California, San FranciscoOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT05807074 | Impact of Topical Tranexamic Acid in Breast Reconstruction | terminated | Phase 4 | 23 | University of California, San FranciscoOTHER | 1 | Sep 29, 2025 | clinicaltrials |
| NCT05014841 | The Neural Coding of Speech Across Human Languages | enrolling by invitation | N/A | 52 | University of California, San FranciscoOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT01734512 | PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children | completed | Phase 2 | 65 | University of California, San FranciscoOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT05789862 | Behavioral Health Evaluation and Intervention Program for Patients Undergoing Craniotomy | withdrawn | N/A | 0 | University of California, San FranciscoOTHER | 0 | Aug 29, 2025 | clinicaltrials |
| NCT05000905 | Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training | withdrawn | N/A | 0 | University of California, San FranciscoOTHER | 0 | Aug 6, 2025 | clinicaltrials |
| NCT01748149 | Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas | completed | Early Phase 1 | 40 | University of California, San FranciscoOTHER | 2 | Aug 3, 2025 | clinicaltrials |
| NCT07087145 | Feasibility of HPV Testing With Mail-delivered Sample Collection Kits | recruiting | — | 135 | University of California, San FranciscoOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT05169944 | Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors(PNOC025) | completed | Phase 1 | 13 | University of California, San FranciscoOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT05294640 | Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures | completed | Phase 4 | 95 | University of California, San FranciscoOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT02078726 | Glucagon Use in Colonoscopies | completed | Phase 4 | 100 | University of California, San FranciscoOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT03094052 | Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib | completed | Phase 2 | 11 | University of California, San FranciscoOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT05342675 | Effect of Rapid Rollover on Pneumothorax After CT-Guided Lung Biopsy | completed | N/A | 54 | University of California, San FranciscoOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT05021185 | Interactive Mobile Doctor (iMD) to Promote Tobacco Cessation Among Cancer Patients | completed | N/A | 30 | University of California, San FranciscoOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT03554044 | T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer | completed | Phase 1 | 20 | University of California, San FranciscoOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT03534141 | Mild Hypothermia and Acute Kidney Injury in Liver Transplantation(MHALT) | terminated | N/A | 175 | University of California, San FranciscoOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT06140927 | Effect of Ketamine on Intraoperative Motor Evoked Potentials | recruiting | Phase 3 | 20 | University of California, San FranciscoOTHER | 1 | May 7, 2025 | clinicaltrials |
| NCT04772469 | Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men | completed | N/A | 934 | University of California, San FranciscoOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT02435472 | Active Surveillance Exercise Clinical Trial(ASX) | completed | N/A | 104 | University of California, San FranciscoOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT04542382 | Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)(BCRPmarker) | completed | Phase 1 | 11 | University of California, San FranciscoOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT05695898 | XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) in Treating Melanoma Prior Immune Checkpoint Inhibitor Therapy | terminated | Phase 1 | 6 | University of California, San FranciscoOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT03396926 | Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer | completed | Phase 2 | 44 | University of California, San FranciscoOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT03805594 | 177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 43 | University of California, San FranciscoOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT05374304 | Decision Making for Older Adults With Cancer | completed | N/A | 65 | University of California, San FranciscoOTHER | 1 | Jan 23, 2025 | clinicaltrials |
| NCT04191057 | Determining Normal Range for Free Light Chains in Serum Among Twins | completed | N/A | 32 | University of California, San FranciscoOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT03982459 | National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC | completed | N/A | 76 | University of California, San FranciscoOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT03248570 | Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects | completed | Phase 2 | 26 | University of California, San FranciscoOTHER | 1 | Nov 20, 2024 | clinicaltrials |
| NCT06217536 | Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas | withdrawn | Phase 1 / Phase 2 | 0 | University of California, San FranciscoOTHER | 0 | Nov 18, 2024 | clinicaltrials |
| NCT03153982 | Ruxolitinib in Operable Head and Neck Cancer | terminated | Phase 2 | 16 | University of California, San FranciscoOTHER | 1 | Oct 30, 2024 | clinicaltrials |
| NCT06182410 | Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma | withdrawn | Phase 2 | 0 | University of California, San FranciscoOTHER | 0 | Aug 7, 2024 | clinicaltrials |
| NCT06501716 | ICG Angiogram as a Predictor of Postoperative Visual Function After EEA Surgery | unknown | — | 40 | University of California, San FranciscoOTHER | 1 | Jul 22, 2024 | clinicaltrials |
| NCT06495580 | Optic Nerve Stimulation To Prevent Visual Deficits After Endoscopic Cranial Approaches | not yet recruiting | N/A | 20 | University of California, San FranciscoOTHER | 1 | Jul 12, 2024 | clinicaltrials |
| NCT03316274 | Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma | completed | Early Phase 1 | 12 | University of California, San FranciscoOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT02303470 | PCOS & Insulin Resistance Exercise Study | unknown | N/A | 47 | University of California, San FranciscoOTHER | 1 | Jun 20, 2024 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials